The Pramodini Medicare IPO is an SME book-built issue that opens on August 12, 2026 and closes on August 14, 2026, with a price band of ₹110 to ₹118 per share and a lot size of 1,200 shares. This page lists the published terms only. It does not assess whether the issue is suitable for you.
Pramodini Medicare IPO details at a glance
Figures below are as published in the IPO filing as of early August 2026. Always reconfirm against the offer document and exchange notices before relying on any number.
Detail | Information |
IPO Type | Book-Built Issue (SME) |
Price Band | ₹110 to ₹118 per equity share |
Face Value | ₹10 per equity share |
Lot Size | 1,200 shares per lot |
Minimum Retail Investment | Approx. ₹1,41,600 (1 lot at upper price band) |
Total Issue Size | Approx. ₹69.04 crore |
Shares on Offer | Approx. 58.51 lakh equity shares |
Offer for Sale (OFS) | 5,00,400 equity shares |
Anchor Investor Bidding Date | August 11, 2026 |
IPO Open Date | August 12, 2026 |
IPO Close Date | August 14, 2026 |
Listing Date (Tentative) | August 19, 2026 |
Listing Platform | NSE SME |
Investor Quota | QIB: 50% | NII/HNI: 15% | Retail: 35% |
What one lot actually costs
This is an SME issue, so the lot size is larger than a typical mainboard IPO. One lot consists of 1,200 shares, and at the upper end of the price band, ₹118, one lot works out to approximately ₹1,41,600. Because this amount is already close to the ₹2,00,000 retail investment cap set by SEBI, most retail applicants are only able to bid for a single lot — a second lot would push the application past the retail category limit and shift it into the Non-Institutional Investor (NII) category instead.
SME IPO vs mainboard IPO: A quick note for beginners
Pramodini Medicare is listed on the NSE SME platform, which is a separate segment from the mainboard (where large, well-established companies list). SME IPOs typically have larger lot sizes, lower overall issue sizes, and can see wider price swings after listing due to comparatively lower trading volumes and liquidity. These are structural features of the SME segment rather than a comment on this specific company, but they are useful basics to understand before evaluating any SME issue.
Issue structure: fresh issue and offer for sale
The ₹69.04 crore issue includes both a fresh issue of new shares and an offer for sale of 5,00,400 equity shares by existing shareholders. Proceeds from the fresh issue portion go to the company, while proceeds from the offer-for-sale portion go to the selling shareholders. The issue also carries a separate market maker reservation and an anchor investor portion, both allotted outside the regular retail, NII, and QIB categories.
How the application process works
For a first-time applicant, the process is done digitally through a broker or bank, and follows a standard sequence:
• Log in to your broker's app or your bank's net banking portal that offers IPO applications.
• Select the IPO from the list of currently open issues.
• Enter the number of lots you wish to bid for and choose a price within the band, or select the cut-off price option.
• Provide your UPI ID (if applying via UPI) or use ASBA through net banking.
• Approve the UPI mandate request in your UPI app to block the required funds.
• Funds are only blocked, not debited, until allotment. If shares are not allotted, the blocked amount is released back to you.
IPO timeline
• Anchor investor bidding: August 11, 2026
• Issue opens: August 12, 2026
• Issue closes: August 14, 2026
• Basis of allotment: expected around August 18, 2026
• Refunds / unblocking of funds and demat credit: on or around August 18, 2026
• Expected listing: August 19, 2026
Dates are indicative and are frequently revised by the issuer, registrar, or exchange. Confirm the finalised schedule closer to the issue open date.
A quick snapshot of the business
For context, the company is a technology-enabled diagnostic services provider operating across radiology, clinical laboratory, and nuclear medicine segments, serving public hospitals, private hospitals, public sector undertakings, and medical colleges across multiple Indian cities. Its recent financial filings show growth in both revenue and profit over the last couple of years, which is one of several factors — alongside valuation, industry outlook, business risk, and liquidity considerations specific to the SME segment — that are typically studied while evaluating any IPO.
Frequently Asked Questions
Ques: What is the Pramodini Medicare IPO price band?
Ans: The published price band is ₹110 to ₹118 per equity share.
Ques: What is the lot size for this IPO?
Ans: One lot consists of 1,200 shares. At the upper price band, this works out to approximately ₹1,41,600 for the minimum application.
Ques: When does the Pramodini Medicare IPO open and close?
Ans: The issue opens on August 12, 2026 and closes on August 14, 2026.
Ques: When is the allotment date and listing date?
Ans: The basis of allotment is expected around August 18, 2026, with listing tentatively scheduled for August 19, 2026 on the NSE SME platform.
Ques: What is the total issue size, and how is it structured?
Ans: The total issue size is approximately ₹69.04 crore, comprising a fresh issue of new shares and an offer for sale of 5,00,400 equity shares by existing shareholders.
Ques: How many lots can a retail investor apply for?
Ans: Since one lot already costs close to the SEBI retail investment cap of ₹2,00,000, most retail investors will be limited to applying for a single lot at the upper price band.
Ques: Is this a mainboard IPO or an SME IPO?
Ans: This is an SME IPO, listing on the NSE SME platform, which is a separate segment from the mainboard with its own listing norms, lot sizes, and liquidity characteristics.
Ques: Can I apply using UPI?
Ans: Yes. Applications can be made using UPI through a broker, or via ASBA through net banking. In both cases, funds are blocked rather than debited until allotment is finalised.
Ques: Should I apply to this IPO?
Ans: This page does not make that call. It sets out the published terms so you can read the offer document and evaluate it independently, or consult a SEBI-registered investment adviser.
Ques: Is IPO allotment guaranteed if I apply?
Ans: No. Allotment is not guaranteed, particularly if the issue is oversubscribed. Shares are allotted through a lottery-based or proportionate process depending on the investor category.
Disclaimer:
This is written for educational and informational purposes only. Nothing here constitutes investment advice or a recommendation to buy or sell securities. All data is sourced from publicly available information. Investments in securities markets are subject to market risks — please read all offer documents carefully before investing.
